Hadassah Begins New Clinical Drug Trial for COVID-19 Patients

Monday, Apr 13 2020

Prof. Eyal Mishani

The Hadassah Medical Organization has begun clinical trials of a drug that may help in the treatment of COVID-19 patients currently hospitalized in the Outbreak Unit at Hadassah Hospital Ein Kerem. The drug, Camostat Mesylate, is used in Japan to treat pancreatitis. Head of Hadassah’s Nuclear Medicine Institute Prof. Eyal Mishani initially procured 7,000 pills for treating COVID-19 patients.

“A basic study by a team of German researchers found that the drug inhibits the infection of healthy cells in human tissue through the ACE-2 receptor,” says Mishani. “In an article published in the last few days in the journal CELL, the researchers explained how the virus enters the cells and how the drug can significantly stop entry. The drug is approved for use in Japan for other purposes and now in the clinical test it will be given to COVID-19 patients at Hadassah.”

The criteria for patient selection were defined by a Hadassah team in a proposal approved by the Helsinki Committee responsible for medical trials in humans. Those in the early stages of COVID-19 will take three pills daily for five days. Initially, 10 patients aged 40 to 80 who are in mild to moderate condition will be selected. This is in addition to a trial just beginning using another Japanese drug, Avigan. That trial is taking place in several Israeli hospitals, including Hadassah, on 80 patients, all in the early stages of COVID-19.

Related Stories


Thursday, May 21 2020

Hadassah Doctor to Study Link Between Sleep Apnea and Diabetes

It is well known that sleep apnea, a condition where breathing repeatedly stops and starts during sleep, can cause...


Thursday, May 21 2020

Best Practices to Fight COVID-19: Hadassah Shares Promising Strategies

Featured on a webinar hosted by David Bernstein, president of the Jewish Council for Public Affairs, and Janice Weinman, chief executive officer of Hadassah, Prof. Yoram Weiss, director of Hadassah Hospital Ein Kerem, told viewers how Israel and Hadassah have so far successfully stopped COVID-19 from raging, despite the recent opening up of the country.


Friday, May 15 2020

Hadassah Saves Preschooler Following Deathstalker Scorpion Bite

When a 4-year-old girl was recently stung by a yellow scorpion known as the deathstalker, one of her parents decided to try a home cure first.


Friday, May 15 2020

A Personal Hour With Hadassah Hospital Senior Staff During COVID-19

What makes the Hadassah Medical Organization unique in the global fight against the COVID-19 pandemic?


Donation Questions


(800) 928-0685

Membership Questions


(800) 664-5646

Israel Travel


(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005


More ›

Show More